Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Pathologica|April 9, 2026
Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian projectBruna Cerbelli, Stefano Marletta, Michelina Amato, et al.
Histopathology|April 15, 2025
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck regionCostantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.
Breast (Edinburgh, Scotland)|March 12, 2014
Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off valuesGábor Cserni, András Vörös, Inta Liepniece-Karele, et al.
Head & Neck|January 29, 2021
Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: Italian multicenter studyDavide B Gissi, Luca Morandi, Giuseppe Colella, et al.
Scientific Reports|January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograftLorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 24, 2026
A Worldwide Survey on Pathological Measurement of Residual Breast Cancer After Neoadjuvant Therapy: Different Interpretations of the ypTNM ClassificationKoen Kwakkenbos, Mieke R Van Bockstal, Abeer M Shaaban, et al.
Cancers|September 10, 2021
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast CancerDarren Kilmartin, Mark O'Loughlin, Xavier Andreu, et al.
Life (Basel, Switzerland)|April 26, 2025
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes TumorsFlavia De Lauretis, Alejandro Martin Sanchez, Cristina Accetta, et al.
BMC Medicine|November 22, 2019
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trialMaria Vittoria Dieci, Giancarlo Bisagni, Alba A Brandes, et al.
Pageof 11